Abstract
Objective: To identify epidemiological variables in records of patients who died with tuberculosis as an underlying or contributing cause, in a state reference hospital for infectious diseases. Methods: This is a cross-sectional and retrospective study based on secondary data from physical records, electronic medical records, and death certificates from 2021 to 2023, in Pará, Brazil. Deaths mentioning tuberculosis in any cause were included. Descriptive statistics, chi-square tests, and regression models were applied to identify factors associated with mortality. Cases later excluded by the Epidemiological Surveillance Unit were not considered. Results: Most patients were male, of working age, with comorbidities such as sepsis, respiratory failure, and malnutrition. TB-HIV coinfection was found in 45.88% of cases, worsening clinical outcomes. Furthermore, 41.18% were malnourished, compromising immune response. Socially, 88.24% of deaths occurred among mixed-race individuals, reflecting racial inequalities. Treatment discontinuity and drug resistance were additional barriers to disease control. Conclusion: The study highlights the need for intersectoral public policies integrating early diagnosis, effective clinical management, social support, and expansion of the Family Health Strategy, especially in peripheral and vulnerable areas.
References
BHARGAVA A, et al. Under nutrition and the incidence of tuberculosis in India: National Family Health Survey. Public Health Nutrition, 2013; 16(9): 1575-1583.
BRASIL. MINISTÉRIO DA SAÚDE. Boletim Epidemiológico de Tuberculose 2013-2022. Brasília, 2022. Disponível em: https ://www.gov.br/aids/pt-br/central-de-conteudo/publicacoes/2022/boletim-epidemiologico-de-tuberculose-201 3-2022. Acesso em: 9 mar. 2025.
BRASIL. MINISTÉRIO DA SAÚDE. Boletim Epidemiológico de Tuberculose: 2024. Brasília, 2024.
BRASIL. MINISTÉRIO DA SAÚDE. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Brasil Livre da Tuberculose: Plano Nacional pelo Fim da Tuberculose como Problema de Saúde Pública: estratégias para 2021-2025. Brasília: Ministério da Saúde, 2021.
BRASIL. MINISTÉRIO DA SAÚDE. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Recomendações para controle da tuberculose: guia rápido para profissionais de saúde. Brasília: Ministério da Saúde, 2021; 2: 47.
BRASIL. MINISTÉRIO DA SAÚDE. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Manual de Recomendações para o controle da tuberculose no Brasil. Brasília, 2019; 364.
CEGIELSKI JP e MC MURRAY DN. The relationshipbetweenmalnutritionandtuberculosis: Evidencefromstudies in humansand experimental animals. InternationalJournalofTuberculosisand Lung Disease, 2012; 8(3): 286-298.
CONASS. Resolução nº 709, de 16 de março de 2023. Disponível em: https ://www.conass.org.br. Acesso em: 15 dez. 2024.
ELLAHI A, et al. Tuberculosis as a riskfactor for lungcancer: A systematic review. International Journal of Epidemiology, 2021; 50(2): 233-242.
GOMES T, et al. Factors associated with tuberculosis mortality: A systematic review. Clinical Epidemiology, 2020; 12: 1-8.
LI X, et al. The associationbetweentuberculosisandlungcancer: A meta-analysisofobservationalstudies. Lung Cancer, 2022; 164: 146-153.
LIMA SS, et al. Análise espacial da tuberculose em Belém, estado do Pará, Brasil. Revista Pan-Amazônica de Saúde, 2017; 8(2): 55-63.
MACIEL EL, et al. Coinfecção TB-HIV: Impacto na morbimortalidade. Jornal Brasileiro de Pneumologia, 2018; 46(2): 20180467.
NOGUEIRA LM, et al. Geospatialpatternsoftuberculosis in urbanareas. BMC Public Health, 2020; 20(1): 294.
PASIPANODYA JG, et al. Pulmonaryimpairmentaftertuberculosis. ChestJournal, 2017; 131(6): 1817-1824.
PINTO PFPS, et al. Performance evaluationoftuberculosiscontrol in Brazilianmunicipalities. Revista de Saúde Pública, 2022; 56: 53.
SALLES CL, et al. Tuberculosis in indigenouspopulations in Brazil: Epidemiological trends andcontrolmeasures. Revista Panamericana de Salud Pública, 2019; 46: 69.
SILVA LM, et al. Fatores associados aos desfechos desfavoráveis de tratamento da tuberculose em idosos no Brasil. Revista Brasileira de Geriatria e Gerontologia, 2024; 27: 230244.
SINGH A, et al. Chronicinflammationand its role in cancerprogression. JournalofCancerResearchandTherapeutics, 2020; 16(4): 567-573.
STEINGART KR, et al. Xpert MTB/RIF assay for pulmonar tuberculosis and rifampicin resistance in adults. Cochrane Database of Systematic Reviews, 2014.
WHO. WORLD HEALTH ORGANIZATION. Global Tuberculosis Report 2022. Disponível em: https ://www.who.int/ publicatio ns/i/item/9789240061729.
WHO. WORLD HEALTH ORGANIZATION. Global tuberculosisreport 2021. Disponível em: https ://www.who.int/ publicatio ns/i/item/9789240037021.
WHO. WORLD HEALTH ORGANIZATION. Global tuberculosisreport 2024. Disponível em: https ://www.who.int/ publicatio ns/i/item/9789240101531.
